scholarly article | Q13442814 |
P2093 | author name string | Xiao-Ying Zheng | |
Xiao-Li Chen | |||
Li-Ping Du | |||
Rui-Jin Ran | |||
Shen-Yin Zhu | |||
Xue-Dong Zhang | |||
P2860 | cites work | Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition | Q28343572 |
The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes | Q31131756 | ||
Sensitive blood-retinal barrier breakdown quantitation using Evans blue | Q32061903 | ||
Modeling type 2 diabetes in rats using high fat diet and streptozotocin | Q34407918 | ||
Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats | Q34451224 | ||
Correlation of hemorrhage, axonal damage, and blood-tissue barrier disruption in brain and retina of Malawian children with fatal cerebral malaria | Q35179749 | ||
Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine | Q35594507 | ||
Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation | Q35737263 | ||
Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). | Q35810089 | ||
Rosmarinic acid protects against experimental diabetes with cerebral ischemia: relation to inflammation response | Q36735785 | ||
High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. | Q37094779 | ||
Tight junctions and the modulation of barrier function in disease | Q37139446 | ||
A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus | Q37463920 | ||
The role of inflammation in epilepsy | Q37816957 | ||
HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation | Q37876420 | ||
Prevalence and control of diabetes in Chinese adults | Q40134909 | ||
Role of inflammation in the pathogenesis of diabetic retinopathy | Q41012127 | ||
HMGB1: the missing link between diabetes mellitus and heart failure | Q42940012 | ||
High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. | Q44492248 | ||
Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats | Q44923040 | ||
A central role for inflammation in the pathogenesis of diabetic retinopathy | Q44961996 | ||
Mechanisms involved in the blood-brain barrier increased permeability induced by Phoneutria nigriventer spider venom in rats | Q45114756 | ||
Anti-high mobility group box-1 antibody therapy for traumatic brain injury | Q48401390 | ||
Poly(amido)amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood-brain barrier permeability in streptozotocin diabetes in rats | Q48464918 | ||
Blood-retina-barrier disruption accompanying blood-brain-barrier dysfunction in posterior reversible encephalopathy syndrome | Q48546096 | ||
Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. | Q64958306 | ||
Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products | Q79655377 | ||
The role of high-mobility group box-1 protein in the development of diabetic nephropathy | Q84179987 | ||
[Suppression of retinal angiogenesis by quercetin in a rodent model of retinopathy of prematurity] | Q85390749 | ||
P433 | issue | 11 | |
P921 | main subject | type 2 diabetes | Q3025883 |
P304 | page(s) | 1591-1597 | |
P577 | publication date | 2016-11-18 | |
P1433 | published in | International Journal of Ophthalmology | Q26841911 |
P1476 | title | Upregulated inflammatory associated factors and blood-retinal barrier changes in the retina of type 2 diabetes mellitus model | |
P478 | volume | 9 |
Search more.